Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
System1 A | SST | 30. sep 2024 | 1.12 | +0.90 |
T Stamp A | IDAI | 30. sep 2024 | 0.22 | -1.70 |
T-Mobile US | TMUS | 30. sep 2024 | 206.36 | +0.58 |
T. Rowe Price Blue Chip Growth ETF | TCHP | 30. sep 2024 | 39.64 | +0.46 |
T. Rowe Price Dividend Growth ETF | TDVG | 30. sep 2024 | 40.96 | +0.44 |
T. Rowe Price Equity Income ETF | TEQI | 30. sep 2024 | 41.77 | +0.12 |
T. Rowe Price Group | TROW | 30. sep 2024 | 108.93 | -0.53 |
T. Rowe Price Growth Stock ETF | TGRW | 30. sep 2024 | 37.67 | +0.51 |
T2 Biosystems | TTOO | 30. sep 2024 | 1.97 | -1.50 |
Taboola.com | TBLA | 30. sep 2024 | 3.36 | +2.44 |
Tactile Systems Technology | TCMD | 30. sep 2024 | 14.61 | +2.74 |
Taitron Components A | TAIT | 30. sep 2024 | 2.91 | 0.00 |
Taiwan Fund | TWN | 30. sep 2024 | 43.93 | -2.40 |
Taiwan Index MSCI Ishares | EWT | 30. sep 2024 | 53.87 | -2.94 |
Taiwan Semiconductor Manufacturing ADR | TSM | 30. sep 2024 | 173.67 | -2.42 |
Take-Two Interactive Software | TTWO | 30. sep 2024 | 153.71 | +0.43 |
Takeda Pharmaceutical ADR | TAK | 30. sep 2024 | 14.22 | -2.20 |
TAL Education Group ADR | TAL | 30. sep 2024 | 11.84 | +9.63 |
Talen Energy | TLN | 30. sep 2024 | 178.24 | 0.00 |
Talis Biomedical | TLIS | 30. sep 2024 | 4.38 | 0.00 |
Talkspace | TALK | 30. sep 2024 | 2.09 | +2.96 |
Talos Energy | TALO | 30. sep 2024 | 10.35 | +1.57 |
Talphera | TLPH | 30. sep 2024 | 0.86 | -0.28 |
Tamboran Resources | TBN | 30. sep 2024 | 20.32 | 0.00 |
Tandem Diabetes Care | TNDM | 30. sep 2024 | 42.41 | -0.09 |
Tanger | SKT | 30. sep 2024 | 33.18 | +0.55 |
Tango Therapeutics | TNGX | 30. sep 2024 | 7.70 | +3.08 |
Tantech | TANH | 30. sep 2024 | 0.19 | +4.56 |
Taoping | TAOP | 30. sep 2024 | 0.71 | -8.29 |
Tapestry | TPR | 30. sep 2024 | 46.98 | -2.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.